Community Clinical Oncology Program (CCOP)
St. Mary Mercy Hospital participates in National Cancer Institute (NCI) & Cancer Center sponsored clinical trials through our affiliation with the Michigan Cancer Research Consortium (MCRC). Clinical trials are a treatment option for many people with cancer. A clinical trial is a study that helps doctors and researchers find better ways to prevent, treat or diagnose diseases. Clinical Trials often compare the current accepted cancer care with promising therapy, that experts in the field believe may be better than the current care. This can only be proven through a well designed and controlled clinical trial. Because of progress made through clinical trials, people treated for cancer are living longer.
Through St. Mary Mercy's participation in the Michigan Cancer Research Consortium (MCRC), Community Clinical Oncology Program (CCOP) cancer patients have access to the latest clinical trials and new therapies for cancer treatment normally only offered at major cancer centers, such as the Mayo Clinic and MD Anderson. Working closely with St. Joseph Mercy Hospital in Ann Arbor, the lead institution in the program, our goal is to find better ways to treat and prevent cancer. To do this, clinical trials are conducted as an essential part of research that allows doctors to collect information on potential treatments while making these new treatments available to patients. The Michigan Cancer Research Consortium (MCRC) staff meet regularly with doctors and nurses throughout the United States to review current research and assist in the development of new clinical trials. This means the latest cancer treatments and protocols are available to patients at St. Mary Mercy Hospital.
For more information about clinical trials, please contact our Oncology Research Nurse Coordinator at 734-655-2792.
Visit the Michigan Cancer Research Consortium to learn more about available clinical trials.